Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Obese But Otherwise Healthy Participants: early-phase trial registry
3 of 3 indexed Obese But Otherwise Healthy Participants trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 3 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Obese But Otherwise Healthy Participants: 3 US clinical trials tracked, 3 recruiting.
Obese But Otherwise Healthy Participants is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Corbus Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition obese-but-otherwise-healthy-participants
OPEN 3 | RECR 100% | LATE 0 | EARLY 1 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Obese But Otherwise Healthy Participants lists 3 open slots (100% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Obese But Otherwise Healthy Participants on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Obese But Otherwise Healthy Participants is recruiting above its size-band peers.
3 of 3 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
Corbus Pharmaceuticals
NCT07310901
Pistachio Snacking and Metabolic Flexibility
University of South Carolina
NCT07340125
Fructose Intestinal Gluconeogenesis
Touro University, California
NCT07209202
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Obese But Otherwise Healthy Participants records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Obese But Otherwise Healthy Participants trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Obese But Otherwise Healthy Participants page
3 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Obese But Otherwise Healthy Participants trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Corbus Pharmaceuticals sponsors the most Obese But Otherwise Healthy Participants trials on record, review their full trial history before evaluating a specific study. See Corbus Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obese But Otherwise Healthy Participants condition card totals 3 registered trials; most-linked intervention Pistachio; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.